Global Biomarkers Market to Reach US$ 139.8 Billion by 2028, Impelled by Growing Prevalence of Chronic Diseases

September 29, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global biomarkers market size reached US$ 68.2 Billion in 2022. A biomarker is a measurable indicator of some biological state or condition, often used for the assessment of physiological and pathological processes, as well as pharmacological responses to therapeutic interventions. Biomarkers can be found in various biological specimens such as blood, urine, saliva, and tissue. They are instrumental in diagnosing diseases, monitoring disease progression, and evaluating the effectiveness of treatments. The manufacturing process of biomarkers involves a sequence of intricate steps, from discovery to validation. Initially, a potential biomarker is identified through research often involving high-throughput techniques, such as mass spectrometry or gene sequencing. Post-discovery, the biomarker undergoes rigorous clinical trials to verify its efficacy and safety.

Global Biomarkers Market Trends:

The global market is primarily driven by the growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders, which necessitates early and accurate diagnosis for effective treatment. The escalation in research funding and investment in healthcare infrastructure is another significant booster for the market. Advances in genomics, proteomics, and bioinformatics are paving the way for the discovery of novel biomarkers, thus expanding their applications. Furthermore, technological advancements in medical imaging, biosensors, and lab-on-chip devices are enhancing the detection capabilities of biomarkers. Collaborations between pharmaceutical companies and research institutions are fostering innovation and expediting the commercialization process. The rise in personalized medicine and the advent of minimally invasive biomarker technologies are additional trends shaping the market landscape. Regulatory support and the increasing focus on patient-centric approaches are also serving as catalysts for market growth. Other factors, including rapid urbanization and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market. Looking forward, the market value is projected to reach US$ 139.8 Billion by 2028, expanding at a CAGR of 11.5% during 2023-2028. 

Market Summary:

  • On the basis of the product, the market has been categorized into consumables, services, and software. Presently, consumables represent the largest segment.
  • Based on the type, the market has been segmented into efficacy, safety, and validation biomarkers. Currently, safety biomarkers dominate the market.
  • On the basis of the disease, the market has been bifurcated into cancer, cardiovascular disorders, neurological disorders, immunological disorders, renal disorders, and others. Among these, cancer account for the largest market share. 
  • Based on the application, the market has been segmented into diagnostics, drug discovery and development, personalized medicine, and others. Currently, drug discovery and development dominate the market.
  • On the basis of the end user, the market has been bifurcated into pharmaceutical and biotechnology companies, diagnostic and research laboratories, hospitals and specialty clinics, and others. Among these, diagnostic and research laboratories account for the largest market share. 
  • Region-wise, the market has been segregated into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Among these, North America holds a leading position in the market.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Epigenomics AG, Eurofins Scientific SE, Merck KGaA, Perkinelmer Inc., Qiagen N.V, Quanterix Corporation, SphingoTec GmbH and Thermo Fisher Scientific Inc. 

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Product
  • Type
  • Disease
  • Application
  • End User
  • Region
Products Covered Consumables, Services, Software
Types Covered Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers
Diseases Covered Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, Others
Applications Covered Diagnostics, Drug Discovery and Development, Personalized Medicine, Others
End Users Covered Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Epigenomics AG, Eurofins Scientific SE, Merck KGaA, Perkinelmer Inc., Qiagen N.V, Quanterix Corporation, SphingoTec GmbH, Thermo Fisher Scientific Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Biomarkers Market to Reach US$ 139.8 Billion by 2028, Impelled by Growing Prevalence of Chronic Diseases
Purchase options Year End sale

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More